Maternal Health, Dengue Fever and Patient Engagement are interminable societal issues. The Synergist believes a systematic approach is required to deal with these types of challenges
Introduction
A systematic approach is required
Maternal Health, Dengue Fever and Patient Engagement are interminable societal issues. It is unlikely that there will be a point in time in which we cannot further improve women’s health, further decrease the burden of dengue or improve new medicines development for with patients. The Synergist believes a systematic approach is required to deal with these types of challenges, we which we seek to do across different levels:
- At the overall Synergist ecosystem level, where we seek to create a robust and replicable model for collaboration on societal challenges
- At the individual initiative ecosystem level (Break Dengue, Patient Focused Medicines Development, Motherhood Collective Impact Programme)
- Through specific projects that benefit from collaboration and digital synergies and which create new opportunities, tools and solutions to face societal issues
Highlights
Meaningful numbers
2
new projects
9
new partners, bringing us to a total of 43
1.782.500 €
of funding raised
887
experts in our patient engagement ecosystem
1.310
experts in our dengue ecosystem
5.079.23
visits on our projects websites
editorial pieces
1
scientific publication
265.437
followers of our social channels
15.284.506
people saw our messages on social media
479.234
people actively engaged on social media
Our partners
The Synergist Ecosystem
A total of 43 partners have decided to join forces to support and push forward our initiatives. This represents a major change in philosophy that has already started generating significant output on all projects. Our corporate partners especially are getting out of the competitive mode in order to have a positive societal impact and operate in a positive societal environment. We believe the full benefits of co-creation and collaboration are yet to be seen.
Financial report
Impact at the collaborative platform or project level is described in the sections specific to each initiative:
- Patient Focused Medicines Development
- Motherhood Collective Impact Programme
- Break Dengue
| Patient Focused Medicines Development (PFMD) |
Break Dengue | Motherhood Collective Impact Program (MCI)* |
|
|---|---|---|---|
| Project Turnover (€) | 1.030.000 | 390.000 | 210.000 |
| Project Expenses (€) | 641.421 | 165.695 | 95.466 |
| In-kind hours | 1.935 | 200 | 100 |
| In-kind contribution (€) | 125.775 | 13.000 | 6.500 |